Skip to main content

ADVERTISEMENT

Ignace Vergote, MD, PhD

Ignace Vergote, MD, PhD
Conference Coverage
11/08/2023
Ignace Vergote, MD, PhD, discusses results from the phase 3 innovaTV 301/ENGOT-cx12/GOG-3057 trial.
Ignace Vergote, MD, PhD, discusses results from the phase 3 innovaTV 301/ENGOT-cx12/GOG-3057 trial.
Ignace Vergote, MD, PhD,...
11/08/2023
Oncology